Imaging brain functional and metabolic changes in restless legs syndrome

Current Neurology and Neuroscience Reports

Volumn 13, Issue 9, 2013, Pages

  Rizzo, Giovanni ^a,b   Tonon, Caterina ^a   Manners, David ^a   Testa, Claudia ^a   Lodi, Raffaele ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b IRCCS ISTITUTO DELLE SCIENZE NEUROLOGICHE DI BOLOGNA   (Italy)

Author keywords

Diffusion tensor imaging; Dopamine; Functional; Functional magnetic resonance imaging; Imaging; Iron; Limbic system; Magnetic resonance imaging; Magnetic resonance spectroscopy; Mesolimbic system; Metabolic; Nigrostriatal system; Nociceptive system; Pathophysiology; Phase imaging; Positron emission tomography; Relaxometry; Restless legs syndrome; Sensorimotor system; Single photon emission computed tomography; Voxel based morphometry

Indexed keywords

DOPAMINE; IRON;

ANIMAL; BRAIN; HUMAN; METABOLISM; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PATHOPHYSIOLOGY; PROCEDURES; RESTLESS LEGS SYNDROME; METHODOLOGY; REVIEW;

ANIMALS; BRAIN; DOPAMINE; HUMANS; IRON; MAGNETIC RESONANCE IMAGING; RESTLESS LEGS SYNDROME;

EID: 84885136041     PISSN: 15284042     EISSN: 15346293     Source Type: Journal    
DOI: 10.1007/s11910-013-0372-1     Document Type: Article

References (61)

1. Trenkwalder C, Paulus W, Walters AS. The restless legs syndrome. Lancet Neurol. 2005;4:465-75. (Pubitemid 40982457)
2. Allen RP, Picchietti D, Hening WA, et al. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med. 2003;4:101-19. (Pubitemid 36527231)
3. Bassetti CL, Mauerhofer D, Gugger M, et al. Restless legs syndrome: a clinical study of 55 patients. Eur Neurol. 2001;45:67-74. (Pubitemid 32215793)
4. Zucconi M, Ferini-Strambi L. Epidemiology and clinical findings of restless legs syndrome. Sleep Med. 2004;5:293-9. (Pubitemid 38684226)
5. Walters AS. Toward a better definition of the restless legs syndrome. The International Restless Legs Syndrome Study Group. Mov Disord. 1995;10:634-42.
6. San Pedro EC, Mountz JM, Mountz JD, et al. Familial painful restless legs syndrome correlates with pain dependent variation of blood flow to the caudate, thalamus, and anterior cingulate gyrus. J Rheumatol. 1998;25:2270-5. (Pubitemid 28505880)
7. Eisensehr I, Wetter TC, Linke R, et al. Normal IPT and IBZM SPECT in drug-naive and levodopa-treated idiopathic restless legs syndrome. Neurology. 2001;57:1307-9. (Pubitemid 32947394)
8. Tribl GG, Asenbaum S, Klosch G, et al. Normal IPT and IBZM SPECT in drug naive and levodopa-treated idiopathic restless legs syndrome. Neurology. 2002;59:649-50. (Pubitemid 34920017)
9. Michaud M, Soucy JP, Chabli A, et al. SPECT imaging of striatal pre and postsynaptic dopaminergic status in restless legs syndrome with periodic leg movements in sleep. J Neurol. 2002;249:164-70. (Pubitemid 34143470)
10. Linke R, Eisensehr I, Wetter TC, et al. Presynaptic dopaminergic function in patients with restless legs syndrome: are there common features with early Parkinson's disease? Mov Disord. 2004;19:1158-62. (Pubitemid 39429956)
11. Mrowka M, Jobges M, Berding G, et al. Computerized movement analysis and beta-CIT-SPECT in patients with restless legs syndrome. J Neural Transm. 2005;112:693-701. (Pubitemid 40591201)
12. Kim KW, Jhoo JH, Lee SB, et al. Increased striatal dopamine transporter density in moderately severe old restless legs syndrome patients. Eur J Neurol. 2012;19:1213-8.
13. Staedt J, Stoppe G, Kögler A, et al. Dopamine D2 receptor alteration in patients with periodic movements in sleep (nocturnal myoclonus). J Neural Transm. 1993;93:71-4. (Pubitemid 23235620)
14. Staedt J, Stoppe G, Kögler A, et al. Nocturnal myoclonus syndrome (periodic movements in sleep) related to central dopamine D2-receptor alteration. Eur Arch Psychiatry Clin Neurosci. 1995;245:8-10.
15. Staedt J, Stoppe G, Kögler A, et al. Single photon emission tomography (SPET) imaging of dopamine D2-receptors in the course of dopamine replacement therapy in patients with nocturnal myoclonus syndrome (NMS). J Neural Transm. 1995;99:187-93.
16. Jhoo JH, Yoon IY, Kim YK, et al. Availability of brain serotonin transporters in patients with restless legs syndrome. Neurology. 2010;74:513-8. This SPECT study disclosed an inverse correlation between the severity of symptoms and the availability of serotonin transporter in patients with RLS, partially supporting the involvement of serotonergic neurotransmission in the disease.
17. Trenkwalder C, Walters AS, Hening WA, et al. Positron emission tomographic studies in restless legs syndrome. Mov Disord. 1999;14:141-5. (Pubitemid 29224690)
18. Ruottinen HM, Partinen M, Hublin C, et al. An FDOPA PET study in patients with periodic limb movement disorder and restless legs syndrome. Neurology. 2000;54:502-4. (Pubitemid 30078095)
19. 11C-raclopride PET studies. Neurology. 1999;52:932-7. (Pubitemid 29161599)
20. Earley CJ, Kuwabara H, Wong DF, et al. The dopamine transporter is decreased in the striatum of subjects with restless legs syndrome. Sleep. 2011;34:341-7.
21. d ), which were unchanged, suggesting increased level of synaptic dopamine.
22. 11 C]raclopride binding potential was significantly lower in the mesolimbic dopamine region (nucleus accumbens and caudate) and not in the nigrostriatal dopamine region (putamen) in the RLS group, and correlated negatively with clinical severity scores and positively with the degree of improvement after dopaminergic treatment.
23. Cervenka S, Pålhagen SE, Comley RA, et al. Support for dopaminergic hypoactivity in restless legs syndrome: a PET study on D2-receptor binding. Brain. 2006;129:2017-28. (Pubitemid 44289067)
24. 11C]diprenorphine PET study. Brain. 2005;128:906-17. (Pubitemid 40516927)
25. Bucher SF, Seelos KC, Oertel WH, et al. Cerebral generators involved in the pathogenesis of the restless legs syndrome. Ann Neurol. 1997;41:639-45. (Pubitemid 27212658)
26. Spiegelhalder K, Feige B, Paul D, et al. Cerebral correlates of muscle tone fluctuations in restless legs syndrome: a pilot study with combined functional magnetic resonance imaging and anterior tibial muscle electromyography. Sleep Med. 2008;9:177-83.
27. Astrakas LG, Konitsiotis S, Margariti P, et al. T2 relaxometry and fMRI of the brain in late-onset restless legs syndrome. Neurology. 2008;71:911-6.
28. • Margariti PN, Astrakas LG, Tsouli SG, et al. Investigation of unmedicated early onset restless legs syndrome by voxel-based morphometry, T2 relaxometry, and functional MR imaging during the night-time hours. AJNR Am J Neuroradiol. 2012;33:667-72. In this MRI study, fMRI was used along with other techniques to show activation of the striatofrontolimbic area in RLS patients. The authors suggested that this finding may represent the neurofunctional substrate mediating the repetitive compulsive movements seen in RLS.
29. Etgen T, Draganski B, Ilg C, et al. Bilateral thalamic gray matter changes in patients with restless legs syndrome. Neuroimage. 2005;24:1242-7. (Pubitemid 40164526)
30. Unrath A, Juengling FD, Schork M, Kassubek J. Cortical grey matter alterations in idiopathic restless legs syndrome: an optimized voxel-based morphometry study. Mov Disord. 2007;22:1751-6. (Pubitemid 47597598)
31. Hornyak M, Ahrendts JC, Spiegelhalder K, et al. Voxel-based morphometry in unmedicated patients with restless legs syndrome. Sleep Med. 2007;9:22-6. (Pubitemid 350187591)
32. Connor JR, Ponnuru P, Lee BY, et al. Postmortem and imaging based analyses reveal CNS decreased myelination in restless legs syndrome. Sleep Med. 2011;12:614-9.
33. Celle S, Roche F, Peyron R, et al. Lack of specific gray matter alterations in restless legs syndrome in elderly subjects. J Neurol. 2010;257:344-8.
34. Comley RA, Cervenka S, Palhagen SE, et al. A comparison of gray matter density in restless legs syndrome patients and matched controls using voxel-based morphometry. J Neuroimaging. 2012;22:28-32.
35. Rizzo G, Manners D, Vetrugno R, et al. Combined brain voxel-based morphometry and diffusion tensor imaging study in idiopathic restless legs syndrome patients. Eur J Neurol. 2012;19:1045-9.
36. Unrath A, Müller HP, Ludolph AC, et al. Cerebral white matter alterations in idiopathic restless legs syndrome, as measured by diffusion tensor imaging. Mov Disord. 2008;23:1250-5.
37. 1 H-MRS revealed a medial thalamic NAA/Cr reduction in the patients, interpreted as a metabolic impairment rather than a neuronal loss, with structural thalamic changes having been excluded using DTI, VBM, and volumetric and shape analysis, and highlighting the possible role of limbic system dysfunction in the pathophysiology of RLS.
38. 1 H-MRS study disclosed an increased Glx/Cr ratio in the whole right thalamus of RLS patients, correlated with wake time during the sleep period and all other RLS-related polysomnographic sleep variables except for the number of PLMs per hour. The authors suggested the presence of a glutamatergic disorder in RLS which could underlie the arousal sleep disturbance and not the PLMs.
39. Haacke EM, Cheng NY, House MJ, et al. Imaging iron stores in the brain using magnetic resonance imaging. Magn Reson Imaging. 2005;23:1-25. (Pubitemid 40269946)
40. Allen RP, Barker PB, Wehrl F, et al. MRI measurement of brain iron in patients with restless legs syndrome. Neurology. 2001;56:263-5. (Pubitemid 32095374)
41. Earley CJ, Barker PB, Horska A, Allen RP. MRI-determined regional brain iron concentrations in early- and late-onset restless legs syndrome. Sleep Med. 2006;7:458-61. (Pubitemid 44164164)
42. Godau J, Klose U, Di Santo A, et al. Multiregional brain iron deficiency in restless legs syndrome. Mov Disord. 2008;23:1184-7.
43. Rizzo G, Manners D, Testa C, et al. Low brain iron content in idiopathic restless legs syndrome patients detected by phase imaging. Mov Disord. 2013. doi: 10.1002/mds.25576.
44. Schmidauer C, Sojer M, Seppi K, et al. Transcranial ultrasound shows nigral hypoechogenicity in restless legs syndrome. Ann Neurol. 2005;58:630-4. (Pubitemid 41377229)
45. Godau J, Schweitzer KJ, Liepelt I, et al. Substantia nigra hypoechogenicity: definition and findings in restless legs syndrome. Mov Disord. 2007;22:187-92. (Pubitemid 46374759)
46. Godau J, Wevers AK, Gaenslen A, et al. Sonographic abnormalities of brainstem structures in restless legs syndrome. Sleep Med. 2008;9:782-9.
47. Ryu JH, Lee MS, Baik JS. Sonographic abnormalities in idiopathic restless legs syndrome (RLS) and RLS in Parkinson's disease. Parkinsonism Relat Disord. 2011;17:201-3.
48. Price DD. Psychological and neural mechanisms of the affective dimension of pain. Science. 2000;288:1769-72. (Pubitemid 30399009)
49. Karroum EG, Golmard JL, Leu-Semenescu S, Arnulf I. Sensations in restless legs syndrome. Sleep Med. 2012;13:402-8.
50. Winkelmann J, Prager M, Lieb R, et al. "Anxietas tibiarum". Depression and anxiety disordersin patients with restless legs syndrome. J Neurol. 2005;252:67-71. (Pubitemid 40179020)
51. Cho SJ, Hong JP, Hahm BJ, et al. Restless legs syndrome in a community sample of Korean adults: prevalence, impact on quality of life, and association with DSM-IV psychiatric disorders. Sleep. 2009;32:1069-76.
52. Hornyak M. Depressive disorders in restless legs syndrome: epidemiology, pathophysiology and management. CNS Drugs. 2010;24:89-98.
53. Celle S, Roche F, Kerleroux J, et al. Prevalence and clinical correlates of restless legs syndrome in an elderly French population: the synapse study. J Gerontol A Biol Sci Med Sci. 2010;65:167-73.
54. Pearson VE, Allen RP, Dean T, et al. Cognitive deficits associated with restless legs syndrome (RLS). Sleep Med. 2006;7:25-30. (Pubitemid 43033541)
55. Gamaldo CE, Benbrook AR, Allen RP, et al. A further evaluation of the cognitive deficits associated with restless legs syndrome (RLS). Sleep Med. 2008;9:500-5. (Pubitemid 351837472)
56. Fulda S, Beitinger ME, Reppermund S, et al. Short-term attention and verbal fluency is decreased in restless legs syndrome patients. Mov Disord. 2010;25:2641-8.
57. Walters AS, Rye DB. Review of the relationship of restless legs syndrome and periodic limb movements in sleep to hypertension, heart disease, and stroke. Sleep. 2009;32:589-97.
58. Allen RP, Earley CJ. The role of iron in restless legs syndrome. Mov Disord. 2007;22:S440-8.
59. Connor JR, Wang XS, Allen RP, et al. Altered dopaminergic profile in the putamen and substantia nigra in restless leg syndrome. Brain. 2009;132:2403-12.
60. Burhans MS, Dailey C, Beard Z, et al. Iron deficiency: differential effects on monoamine transporters. Nutr Neurosci. 2005;8:31-8. (Pubitemid 40637245)
61. Ill AM, Mitchell TR, Neely EB, Connor JR. Metabolic analysis of mouse brains that have compromised iron storage. Metab Brain Dis. 2006;21:77-87.